Diabetes Care, Vol 20, Issue 1 12-14, Copyright © 1997 by American Diabetes Association
Measurement of plasma LDL cholesterol in patients with diabetes
MJ Whiting, MD Shephard and GA Tallis
Department of Biochemistry and Chemical Pathology, Flinders Medical Centre, Bedford Park, South Australia. malcolm.whiting@flinders.edu.au
OBJECTIVE: To assess the accuracy of plasma LDL cholesterol concentrations
estimated by the Friedewald formula and a direct immunoseparation method by
comparison with a reference ultracentrifugation procedure in patients with
diabetes. RESEARCH DESIGN AND METHODS: Fasting plasma samples with
triglyceride concentrations < 4.5 mmol/l were collected from 100
patients with diabetes (28 type I and 72 type II) and LDL cholesterol
concentrations were compared by the three methods. RESULTS: LDL cholesterol
values determined by the reference beta-quantitation procedure were highly
correlated with both the Friedewald formula (r = 0.96) and a direct
immunoseparation method (r = 0.92). Calculated (Friedewald) LDL cholesterol
coincided with the reference method with < 10% error in 74% of the total
diabetic group (82% of type I and 68% of type II diabetic patients).
However, agreement between the direct LDL cholesterol and reference methods
was significantly less (P = 0.02), with only 44% of patients having an
error of < 10% (52% of type I and 41% of type II diabetic patients). The
direct immunoseparation method for LDL cholesterol showed a positive bias
with increasing triglyceride concentrations, particularly for patients with
type II diabetes. CONCLUSIONS: In the group of diabetic patients studied
with plasma triglyceride concentrations < 4.5 mmol/l, the Friedewald
formula provided an accurate estimation of LDL cholesterol. The direct
immunoseparation method significantly overestimated LDL cholesterol at
triglyceride levels between 2 and 4.5 mmol/l.